L
Luca Vivona
Publications - 2
Citations - 1
Luca Vivona is an academic researcher. The author has contributed to research in topics: Cancer & Internal medicine. The author has an hindex of 1, co-authored 2 publications receiving 1 citations.
Papers
More filters
Journal ArticleDOI
The value of the multidisciplinary team in metastatic renal cell carcinoma: Paving the way for precision medicine in toxicities management
Michela Roberto,Martina Panebianco,Anna Maria Aschelter,Dorelsa Buccilli,Carmen Cantisani,Salvatore Caponnetto,Enrico Cortesi,Sara d’Amuri,Claudia Fofi,Debora Ierinò,Viviana Maestrini,Paolo Marchetti,Massimo Marignani,Antonio Stigliano,Luca Vivona,Daniele Santini,Silverio Tomao +16 more
TL;DR: In this article , the authors reported a five case series of toxicity events that occurred at their center during treatment for metastatic clear cell renal carcinoma (mRCC) followed by the remarks of physicians from different specialties, pinpointing the relevant role of an integrated and extended multidisciplinary team in a modern model of mRCC patient management.
Journal ArticleDOI
Role of neutrophil-to-lymphocyte, platelet-to-lymphocyte and myelocite-to-lymphocyte ratio as prognostic markers for immunotherapy response in patients with advanced solid tumors, a retrospective analysis from a single institution.
Monica Verrico,Michela Roberto,Giacomo Barchiesi,F. S. Di Lisa,Teresa Arcuri,Luca Vivona,Fernando Fuccillo,Vincenzo Astorino,Dorelsa Buccilli,Giulia Maltese,Mattia Alberto Di Civita,Amedeo Votto,Andrea Ballario,N.J. Cara,Simone De Meo,Vincenzo Bianco,Iolanda Speranza,Andrea Botticelli,Silverio Tomao +18 more
TL;DR: In this article , the associations between neutrophil-to-lymphocyte (NLR), myeloid-tolymphocytes (MLR), and platelet-to lymphocyte (PLR) ratio have been associated with systemic inflammation and some evidences suggest that they could play a role as prognostic factors.